Depression and Female sexual dysfunction
Summary:
Female sexual dysfunction is found among people with Depression, especially for people who are female, 20-29 old.
The study analyzes which people have Female sexual dysfunction with Depression. It is created by eHealthMe based on reports of 54 people who have Depression from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Depression?
Depression is found to be associated with 3,167 drugs and 4,125 conditions by eHealthMe. Check the latest studies of Depression.
What is Female sexual dysfunction?
Female sexual dysfunction (change in sexual function) is found to be associated with 22 drugs and 128 conditions by eHealthMe. Check the latest studies of Female sexual dysfunction.
54 people who have Depression and Female Sexual Dysfunction are studied.

Gender of people who have Depression and experienced Female Sexual Dysfunction *:
- female: 100 %
- male: 0.0 %
Age of people who have Depression and experienced Female Sexual Dysfunction *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 41.86 %
- 30-39: 25.58 %
- 40-49: 30.23 %
- 50-59: 2.33 %
- 60+: 0.0 %
Common co-existing conditions for these people *:
- Panic Disorder: 8 people, 14.81%
- Insomnia (sleeplessness): 7 people, 12.96%
- High Blood Pressure: 5 people, 9.26%
- Stress And Anxiety: 5 people, 9.26%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 5.56%
- Quit Smoking: 3 people, 5.56%
- Psychotic Disorder: 2 people, 3.70%
- Pain: 2 people, 3.70%
- Hypersensitivity: 2 people, 3.70%
- High Blood Cholesterol: 2 people, 3.70%
Common drugs taken by these people *:
- Sertraline: 19 people, 35.19%
- Escitalopram: 5 people, 9.26%
- Ambien: 4 people, 7.41%
- Sertraline Hydrochloride: 4 people, 7.41%
- Wellbutrin: 3 people, 5.56%
- Trintellix: 3 people, 5.56%
- Chantix: 3 people, 5.56%
- Zyprexa: 2 people, 3.70%
- Crestor: 2 people, 3.70%
- Lexapro: 2 people, 3.70%
Common symptoms for these people *:
- Disturbance In Attention: 14 people, 25.93%
- Loss Of Libido (loss of sexual urge): 13 people, 24.07%
- Libido Decreased (loss of interest in sex): 12 people, 22.22%
- Anhedonia (inability to experience pleasure from activities usually found enjoyable): 11 people, 20.37%
- Visual Impairment: 11 people, 20.37%
- Night Sweats (sweating in night): 10 people, 18.52%
- Suicidal Ideation: 9 people, 16.67%
- Erection Problems: 9 people, 16.67%
- Tearfulness (excess tearing): 9 people, 16.67%
- Emotional Poverty: 8 people, 14.81%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Female sexual dysfunction?
- Check whether Female sexual dysfunction is associated with a drug or a conditionRelated publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Depression (652,144 reports)
- Female sexual dysfunction (268 reports)
All the drugs that are associated with Female sexual dysfunction:
- Female sexual dysfunction (22 drugs)
All the conditions that are associated with Female sexual dysfunction:
- Female sexual dysfunction (128 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Female sexual dysfunction and Depression, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Colecalciferol cause Death? - a second ago
- Chemotherapy and Pain Exacerbated - 5 seconds ago
- Drug interactions of Lorazepam and Asenapine - 7 seconds ago
- Could Tequin cause Azotaemia? - 10 seconds ago
- Could Efavirenz cause Seizures? - 19 seconds ago
- Could Aleve cause Stent? - 19 seconds ago
- Could Aleve cause Psoriatic Arthropathy? - 20 seconds ago
- Could Alfuzosin Hydrochloride cause Diarrhea? - 24 seconds ago
- Could Alfuzosin Hydrochloride cause Stools - Watery? - 24 seconds ago
- Drug interactions of Prednisolone Sodium Phosphate and Acetaminophen - 24 seconds ago